1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Merial

Anonymous board for Merial

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    6
    Views:
    2,192
  2. Anonymous
    Replies:
    40
    Views:
    7,612
  3. anonymous
    Replies:
    6
    Views:
    3,144
  4. anonymous
    Replies:
    2
    Views:
    2,828
  5. anonymous
    Replies:
    33
    Views:
    16,760
  6. Anonymous
    Replies:
    231
    Views:
    158,276
  7. anonymous
    Replies:
    2
    Views:
    2,320
  8. anon145
    Replies:
    14
    Views:
    3,484
  9. anonymous
    Replies:
    3
    Views:
    2,538
  10. anonymous
    Replies:
    24
    Views:
    8,144
  11. anonymous
    Replies:
    0
    Views:
    1,568
  12. anonymous
    Replies:
    13
    Views:
    3,167
  13. anonymous
    Replies:
    0
    Views:
    1,529
  14. anonymous
    Replies:
    4
    Views:
    2,446
  15. anonymous
    Replies:
    3
    Views:
    3,503
  16. Anonymous
    Replies:
    11
    Views:
    11,331
  17. anonymous
    Replies:
    7
    Views:
    4,626
  18. anonymous
    Replies:
    0
    Views:
    2,094
  19. fullofquestions
    Replies:
    3
    Views:
    2,709
  20. Anonymous
    Replies:
    33
    Views:
    13,152

Thread Display Options

Loading...